Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices

被引:590
作者
Sturniolo, T
Bono, E
Ding, JY
Raddrizzani, L
Tuereci, O
Sahin, U
Braxenthaler, M
Gallazzi, F
Protti, MP
Sinigaglia, F
Hammer, J [1 ]
机构
[1] Roche Milano Ric, I-20132 Milan, Italy
[2] Hoffmann La Roche Inc, Dept Genom & Informat Sci, Nutley, NJ 07110 USA
[3] Univ Saarlandes, Dept Internal Med, D-66421 Homburg, Germany
[4] San Raffaele Sci Inst, Lab Tumor Immunol, I-20132 Milan, Italy
关键词
HLA matrix; epitope prediction; DNA microarrays; tumor immunology; genomics;
D O I
10.1038/9858
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Most pockets in the human leukocyte antigen-group DR (HLA-DR) groove are shaped by clusters of polymorphic residues and, thus, have distinct chemical and size characteristics in different HLA-DR alleles, Each HLA-DR pocket can be characterized by "pocket profiles," a quantitative representation of the interaction of all natural amino acid residues with a given pocket. In this report we demonstrate that pocket profiles are nearly independent of the remaining HLA-DR cleft. A small database of profiles was sufficient to generate a large number of HLA-DR matrices, representing the majority of human HLA-DR peptide-binding specificity. These virtual matrices were incorporated in software (TEPITOPE) capable of predicting promiscuous HLA class II ligands, This software, in combination with DNA microarray technology, has provided a new tool for the generation of comprehensive databases of candidate promiscuous T-cell epitopes in human disease tissues. First, DNA microarrays are used to reveal genes that are specifically expressed or upregulated in disease tissues. Second, the prediction software enables the scanning of these genes for promiscuous HLA-DR binding sites. In an example, we demonstrate that starting from nearly 20,000 genes, a database of candidate colon cancer-specific and promiscuous T-cell epitopes could be fully populated within a matter of days. Our approach has implications for the development of epitope-based vaccines.
引用
收藏
页码:555 / 561
页数:7
相关论文
共 36 条
[1]   SEQUENCE IDENTIFICATION OF 2,375 HUMAN BRAIN GENES [J].
ADAMS, MD ;
DUBNICK, M ;
KERLAVAGE, AR ;
MORENO, R ;
KELLEY, JM ;
UTTERBACK, TR ;
NAGLE, JW ;
FIELDS, C ;
VENTER, JC .
NATURE, 1992, 355 (6361) :632-634
[2]   COMPLEMENTARY-DNA SEQUENCING - EXPRESSED SEQUENCE TAGS AND HUMAN GENOME PROJECT [J].
ADAMS, MD ;
KELLEY, JM ;
GOCAYNE, JD ;
DUBNICK, M ;
POLYMEROPOULOS, MH ;
XIAO, H ;
MERRIL, CR ;
WU, A ;
OLDE, B ;
MORENO, RF ;
KERLAVAGE, AR ;
MCCOMBIE, WR ;
VENTER, JC .
SCIENCE, 1991, 252 (5013) :1651-1656
[3]   DETECTION OF CIRCULATING ANTIBODIES AGAINST C-MYC PROTEIN IN CANCER-PATIENT SERA [J].
BENMAHREZ, K ;
THIERRY, D ;
SOROKINE, I ;
DANNAMULLER, A ;
KOHIYAMA, M .
BRITISH JOURNAL OF CANCER, 1988, 57 (06) :529-534
[4]   Progress in the Leishmania genome project [J].
Blackwell, JM .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1997, 91 (02) :107-110
[5]   3-DIMENSIONAL STRUCTURE OF THE HUMAN CLASS-II HISTOCOMPATIBILITY ANTIGEN HLA-DR1 [J].
BROWN, JH ;
JARDETZKY, TS ;
GORGA, JC ;
STERN, LJ ;
URBAN, RG ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1993, 364 (6432) :33-39
[6]   Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network [J].
Brusic, V ;
Rudy, G ;
Honeyman, M ;
Hammer, J ;
Harrison, L .
BIOINFORMATICS, 1998, 14 (02) :121-130
[7]   New goals for the US Human Genome Project: 1998-2003 [J].
Collins, FS ;
Patrinos, A ;
Jordan, E ;
Chakravarti, A ;
Gesteland, R ;
Walters, L ;
Fearon, E ;
Hartwelt, L ;
Langley, CH ;
Mathies, RA ;
Olson, M ;
Pawson, AJ ;
Pollard, T ;
Williamson, A ;
Wold, B ;
Buetow, K ;
Branscomb, E ;
Capecchi, M ;
Church, G ;
Garner, H ;
Gibbs, RA ;
Hawkins, T ;
Hodgson, K ;
Knotek, M ;
Meisler, M ;
Rubin, GM ;
Smith, LM ;
Smith, RF ;
Westerfield, M ;
Clayton, EW ;
Fisher, NL ;
Lerman, CE ;
McInerney, JD ;
Nebo, W ;
Press, N ;
Valle, D .
SCIENCE, 1998, 282 (5389) :682-689
[8]   Parasite Genome Projects and the Trypanosoma cruzi genome initiative [J].
Degrave, W ;
Levin, MJ ;
daSilveira, JF ;
Morel, CM .
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 1997, 92 (06) :859-862
[9]   X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II [J].
Dessen, A ;
Lawrence, CM ;
Cupo, S ;
Zaller, DM ;
Wiley, DC .
IMMUNITY, 1997, 7 (04) :473-481
[10]   MHC-DEPENDENT ANTIGEN-PROCESSING AND PEPTIDE PRESENTATION - PROVIDING LIGANDS FOR T-LYMPHOCYTE ACTIVATION [J].
GERMAIN, RN .
CELL, 1994, 76 (02) :287-299